Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 5:54 PM
Ignite Modification Date: 2025-12-24 @ 5:54 PM
NCT ID: NCT04139668
Eligibility Criteria: Inclusion Criteria: * Adult (18-64) male or female (gender to be analyzed as a covariate) * Understand and willing to comply with study requirements and restrictions * Willing to use appropriate contraceptive method throughout the study * Otherwise healthy as judged by investigator based on medical history, physical exam, vitals, ECG and labs * DSM 5 criteria for current CUD * Report cannabis as primary drug of abuse * Have cannabis positive urine drug screen * Treatment seeking cannabis smoker Exclusion Criteria: * Meets DSM 5 criteria for a current axis I disorder including substance use disorder other than cannabis, nicotine or caffeine dependence. * Unstable medical conditions * Pregnant or breast-feeding * Positive urine drug test for opioids (including methadone, morphine, buprenorphine) or benzodiazepines (unless prescribed) at baseline * Any IM gluteal administration 30 days prior to baseline * Participation in a clinical trial of a pharmacological agent within 30 days prior to baseline * Known intolerance and/or hypersensitivity to naltrexone, carboxymethylcellulose, or polylactide-coglycolide * Any finding that, in the view of the principal investigator, would compromise the subject's ability to fulfill the protocol visit schedule or visit requirement (e.g. unadjudicated charges and/or pending parole hearings)
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 64 Years
Study: NCT04139668
Study Brief:
Protocol Section: NCT04139668